This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic). It has no schema of its own: companies here are mapped on the Manufacturing schema, and what it does not cover is recorded as gaps.
| Primitive | Part | Layer | Description | Parameters | Coverage |
|---|---|---|---|---|---|
Plant safety and environment hse | Control: rules the company runs under | Decisions | Machine guarding, chemicals, emissions and waste. | 1 | — |
Quality management system quality_systems | Control: rules the company runs under | Decisions | The documented system that controls processes, records nonconformances and drives corrective action. | 3 | — |
Coverage: the share of the 0 companies mapped in public on Biological Product (except Diagnostic) Manufacturing and below that have the primitive mapped. Primitives are matched by key, so companies on earlier versions count.
Lot traceability traceability |
|---|
| Control: rules the company runs under |
| Data |
| Knowing which material lots went into which finished units and where they were shipped. |
| 2 |
| — |
Strategy and goals strategy | Direction: deciding where it goes | Decisions | What the company is trying to become. | 0 | — |
|---|
Governance and decision rights governance | Direction: deciding where it goes | Decisions | Who decides what, up to which limit. | 0 | — |
|---|
Management cadence cadence | Direction: deciding where it goes | Process | The meetings and reviews that run the company. | 0 | — |
|---|
Learning and improvement improvement | Direction: deciding where it goes | Process | How feedback changes the way work is done. | 0 | — |
|---|